Related Experiment Videos
A mouse model for studying intrahepatic islet transplantation
Manami Hara1, Dengping Yin, Restituto F Dizon
1Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC1027, Chicago, IL 60637, USA. mhara@midway.uchicago.edu
Transplantation
|September 28, 2004
Summary
Researchers visualized intraportal islet transplantation in mice, revealing early beta-cell loss and liver injury. This method aids in studying diabetes mellitus treatments and improving islet transplant success.
Area of Science:
- Endocrinology
- Transplantation Biology
- Regenerative Medicine
Background:
- Intrahepatic islet transplantation offers a potential cure for diabetes mellitus, particularly type 1 diabetes.
- Current challenges include the need for large islet quantities, repeated procedures, poor angiogenesis, and immune rejection.
- Rodent models are crucial for improving islet transplantation, but most studies focus on subcapsular kidney transplants, not intrahepatic models.
Purpose of the Study:
- To develop and validate a method for visualizing intraportal islet transplantation in a rodent model.
- To assess early histologic and pathologic changes in islets and liver tissue following intraportal transplantation.
- To provide insights into the failure mechanisms of intrahepatic islet transplantation.
Main Methods:
- Utilized transgenic mice expressing green fluorescent protein (GFP) under the mouse insulin I promoter for islet tracking.
- Developed a method for intraportal islet transplantation into the liver.
- Employed reflected light confocal imaging to visualize transplanted islets and surrounding hepatic tissue.
- Examined histologic and pathologic changes 24 hours post-transplantation.
Main Results:
- Successfully visualized intraportal islet grafts and associated hepatic tissue using confocal imaging.
- Observed significant beta-cell loss within the first 24 hours after transplantation.
- Identified ischemic injuries in the surrounding hepatic tissue post-transplantation.
- Demonstrated the utility of GFP-expressing islets for tracking and evaluating transplant outcomes.
Conclusions:
- The developed imaging technique allows for detailed monitoring of intraportal islet grafts in vivo.
- Early beta-cell loss and hepatic injury are significant challenges in intrahepatic islet transplantation.
- This model provides a valuable platform for investigating strategies to improve islet graft survival and function.
- Further research is needed to address angiogenesis and immune rejection in intrahepatic islet transplantation.